Insulin B peptide-MHC class II-specific chimeric antigen receptor-Tregs prevent autoimmune diabetes

Adoptive immunotherapy with Tregs is a promising approach for prevention or treatment of type 1 diabetes. Islet antigen-specific Tregs have more potent therapeutic effects than polyclonal cells, but their low frequency is a barrier for clinical application. To generate Tregs that recognize islet ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Spanier, Justin A., Fung, Vivian, Wardell, Christine M., Alkhatib, Mohannad H., Chen, Yixin, Swanson, Linnea A., Dwyer, Alexander J., Weno, Matthew E., Silva, Nubia, Mitchell, Jason S., Orban, Paul C., Mojibian, Majid, Verchere, C. Bruce, Fife, Brian T., Levings, Megan K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980092/
https://www.ncbi.nlm.nih.gov/pubmed/36865264
http://dx.doi.org/10.1101/2023.02.23.529737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980092/
https://www.ncbi.nlm.nih.gov/pubmed/36865264
http://dx.doi.org/10.1101/2023.02.23.529737

Ejemplares similares